This meta-analysis aims to investigate the novel function of ApoE polymorphism in Alzheimer’s disease (AD) development in individuals with type 2 diabetes mellitus (T2DM) to offer valuable insights for AD therapy in T2DM patients and pharmacological research. The gene discussed is APOE; the disease is type 2 diabetes mellitus.